GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Gland Pharma Ltd
Gland Pharma Board Meeting Scheduled for Unaudited Q2 FY27 Results
RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 21 Oct 2026, 05:04 PM IST  ·  BSE ID: ebc986ec-6070-41ed-b0d8-bfd50cdec777
View Original BSE Filing (PDF)
💡
In Simple Terms
Gland Pharma's board will meet on November 06, 2026, to announce its financial results for the quarter ended September 2026.
🤖 AI Summary
  • Gland Pharma Board of Directors to meet on November 06, 2026, to approve Q2 FY27 unaudited financial results.
  • The meeting will consider standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
  • The trading window for Gland Pharma employees will reopen on Monday, November 09, 2026.
  • An investor/analyst call is scheduled for November 06, 2026, at 18:30 Hrs (IST) post results approval.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this intimation.
👤
Who Is Affected
All shareholders of Gland Pharma Limited will be impacted by the financial results to be announced on November 06, 2026, as they will provide an update on the company's performance.
🔍
Management Signal
The scheduling of the board meeting indicates management's adherence to regulatory timelines for financial reporting and transparency.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting outcome on November 06, 2026, for Q2 FY27 financial results.
Detailed unaudited standalone and consolidated financial results for Q2 FY27.
Information from the Investor/Analyst call on November 06, 2026, at 18:30 Hrs (IST).
LOW RISK The filing is a routine regulatory update regarding a scheduled board meeting.
💡 Investor Takeaway
Gland Pharma Limited's Board meeting on November 06, 2026, will consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. This sets the stage for the public release of the company's Q2 FY27 performance.
📅 Company Track Record
Gland Pharma's Q4 FY26 revenue was ₹17,428 Million, up 22% YoY, with adjusted PAT up 97%. The company recommended a final dividend of Rs. 20 per share for FY26.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is the next Board meeting for Gland Pharma Limited?
The next Board of Directors meeting for Gland Pharma Limited is scheduled for Friday, November 06, 2026.
What is the purpose of Gland Pharma's Board meeting on November 06, 2026?
The purpose of Gland Pharma's Board meeting on November 06, 2026, is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.
When will the trading window reopen for Gland Pharma?
The trading window for Gland Pharma, which was closed from October 01, 2026, will reopen on Monday, November 09, 2026.
When is Gland Pharma's Investor/Analyst call scheduled?
Gland Pharma's Investor/Analyst call is scheduled for Friday, November 06, 2026, at 18:30 Hrs (IST).

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.